Top Weight Management and Healthy Living Developments of the Week

1. WHO Issues Groundbreaking Global Guidelines on GLP-1 Medicines for Obesity

On December 1, 2025, the World Health Organization published its first ever global guideline recommending the long-term, continuous use of GLP-1 therapies—such as semaglutide, liraglutide, and tirzepatide—for adults living with obesity. This represents the first efficacious treatment option endorsed internationally to address obesity as a chronic disease, affecting over 1 billion people worldwide.

The WHO highlights that GLP-1 medications improve weight loss by enhancing appetite regulation and glucose metabolism. However, even with rapid manufacturing scale-up, these medicines are projected to reach fewer than 10% of eligible patients by 2030, signaling significant equity and access challenges.

2. U.S. State Medicaid Programs Grapple with Weight-Loss Drug Coverage Amid High Costs

As of early December 2025, several U.S. states including California, New Hampshire, and North Carolina are reconsidering Medicaid coverage of GLP-1 weight-loss drugs due to staggering projected costs. Estimates show that full coverage for the eligible population could cost up to $880 billion annually.

Data indicate most patients discontinue these medications within one year, often due to side effects like gastrointestinal discomfort or costs. Some states are exploring prioritizing coverage of more affordable FDA-approved oral weight-loss pills before adding newer injectable therapies, balancing the potential to stem obesity-related conditions against state budget constraints.

3. Marion Nestle Highlights the Role of Calorie Control within Dietary Guidelines Debates

Nutrition expert Marion Nestle, interviewed December 2, 2025, emphasized that calories remain a core factor in weight management. She noted that approximately 75% of American adults are overweight or obese, mainly due to excess calorie consumption, particularly from ultra-processed foods that promote unconscious overeating.

Nestle advocates for revisiting the traditional food pyramid model, which more clearly communicates healthy eating hierarchies compared to the current MyPlate guidelines, aiming to better inform and support consumers in choosing nutrient-dense foods.

4. Ultra-Processed Foods Now Dominate Caloric Intake and Worsen Health Outcomes

Recent 2025 research shows that ultra-processed foods constitute nearly 60% of calories in U.S. adults’ diets and about 70% for children. A comprehensive meta-analysis of 45 studies involving nearly 10 million people found strong evidence linking high consumption of ultra-processed foods to a 50% higher risk of cardiovascular death, 48% increased risk of anxiety, 55% higher obesity risk, 40% greater risk of type 2 diabetes, and a 21% rise in early mortality.

These foods are engineered to be hyperpalatable yet less satiating, leading to average excess consumption of about 500 calories daily compared to unprocessed diets.

5. Mediterranean and Plant-Based Diets Demonstrate Benefits in Preventing Chronic Constipation

A large-scale study of over 96,000 participants from the Nurses' Health Studies published in late November 2025 found that Mediterranean and plant-based dietary patterns significantly reduce the occurrence of chronic constipation in aging adults. This benefit is independent of fiber intake, suggesting that the overall quality and diversity of plant-forward foods promote gut health.

Interestingly, consumption of Western or inflammatory diets correlated with increased constipation risk, while diets high in vegetables, nuts, and healthy fats provided protective effects beyond traditional fiber-based explanations.

Summary: This week’s top stories highlight a revolution in obesity treatment with new WHO-endorsed drug guidelines, ongoing policy debates on drug affordability and coverage in the U.S., renewed scientific scrutiny on calorie impact and processed foods, and promising diet-based strategies to aid digestive health and metabolic wellness.

Sources

• https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
• https://www.politico.com/news/2025/12/02/weight-loss-medicaid-drugs-ozempic-wegovy-zepbound-00663581
• https://www.statnews.com/2025/12/02/marion-nestle-interview-author-what-to-eat-now/
• https://www.sciencedaily.com/news/health_medicine/nutrition/
• https://www.sciencedaily.com/releases/2025/11/251123115437.htm